Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 8
2013 7
2014 11
2016 2
2017 2
2018 2
2019 3
2020 4
2021 4
2022 2
2023 6
2024 7
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
The nuclear factor ID3 endows macrophages with a potent anti-tumour activity.
Deng Z, Loyher PL, Lazarov T, Li L, Shen Z, Bhinder B, Yang H, Zhong Y, Alberdi A, Massague J, Sun JC, Benezra R, Glass CK, Elemento O, Iacobuzio-Donahue CA, Geissmann F. Deng Z, et al. Among authors: bhinder b. Nature. 2024 Feb;626(8000):864-873. doi: 10.1038/s41586-023-06950-4. Epub 2024 Feb 7. Nature. 2024. PMID: 38326607 Free PMC article.
Immunogenomic Landscape of Neuroendocrine Prostate Cancer.
Bhinder B, Ferguson A, Sigouros M, Uppal M, Elsaeed AG, Bareja R, Alnajar H, Eng KW, Conteduca V, Sboner A, Mosquera JM, Elemento O, Beltran H. Bhinder B, et al. Clin Cancer Res. 2023 Aug 1;29(15):2933-2943. doi: 10.1158/1078-0432.CCR-22-3743. Clin Cancer Res. 2023. PMID: 37223924 Free PMC article.
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.
Altorki NK, Walsh ZH, Melms JC, Port JL, Lee BE, Nasar A, Spinelli C, Caprio L, Rogava M, Ho P, Christos PJ, Saxena A, Elemento O, Bhinder B, Ager C, Amin AD, Sanfilippo NJ, Mittal V, Borczuk AC, Formenti SC, Izar B, McGraw TE. Altorki NK, et al. Among authors: bhinder b. Nat Commun. 2023 Dec 19;14(1):8435. doi: 10.1038/s41467-023-44195-x. Nat Commun. 2023. PMID: 38114518 Free PMC article.
The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis.
Ohara K, Rendeiro AF, Bhinder B, Eng KW, Ravichandran H, Nguyen D, Pisapia D, Vosoughi A, Fernandez E, Shohdy KS, Manohar J, Beg S, Wilkes D, Robinson BD, Khani F, Bareja R, Tagawa ST, Ouseph MM, Sboner A, Elemento O, Faltas BM, Mosquera JM. Ohara K, et al. Among authors: bhinder b. Nat Commun. 2024 Mar 18;15(1):2009. doi: 10.1038/s41467-024-46320-w. Nat Commun. 2024. PMID: 38499531 Free PMC article.
Pan-cancer immune and stromal deconvolution predicts clinical outcomes and mutation profiles.
Bhinder B, Friedl V, Sethuraman S, Risso D, Chiotti KE, Mashl RJ, Ellrott KP, Lee JA, Wong CK, Gyan K, Deshpande A, Imielinski M, Bareja R, Stuart J, Peto M, Hoadley KA, Lazar AJ, Cherniack AD, Zhu J, Cao S, Rubin M, Wang W, Bathe OF, Robine N, Ding L, Laird PW, Zhou W, Shen H, Thorsson V, Yeh JJ, Bailey MH, Zhou DC, Peng XL, Goldman M, Li Y, Korkut A, Sahni N, Hayes DN, Mensah MKA, Felau I, Kemal A, Caesar-Johnson S, Demchok JA, Yang L, Ferguson ML, Tarnuzzer R, Wang Z, Zenklusen JC; Cancer Genome Atlas Analysis Network; Spellman P, Elemento O. Bhinder B, et al. Sci Rep. 2025 Jul 4;15(1):23921. doi: 10.1038/s41598-025-09075-y. Sci Rep. 2025. PMID: 40615649 Free PMC article.
Epigenetic regulation of chromosomal instability by EZH2 methyltransferase.
Bai Y, Agustinus AS, Yomtoubian S, Meydan C, McNally DR, Yoffe L, Hubisz MJ, Tranquille M, Pramod S, Hong C, Plasilova ML, Kapoor AR, Singh A, Withers H, Dow LE, Laughney AM, Bhinder B, Elemento O, Melnick AM, Bakhoum SF, Mittal V. Bai Y, et al. Among authors: bhinder b. Cancer Discov. 2025 Oct 2. doi: 10.1158/2159-8290.CD-25-0947. Online ahead of print. Cancer Discov. 2025. PMID: 41036949
Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation.
Rivas MA, Meydan C, Chin CR, Challman MF, Kim D, Bhinder B, Kloetgen A, Viny AD, Teater MR, McNally DR, Doane AS, Béguelin W, Fernández MTC, Shen H, Wang X, Levine RL, Chen Z, Tsirigos A, Elemento O, Mason CE, Melnick AM. Rivas MA, et al. Among authors: bhinder b. Nat Immunol. 2021 Feb;22(2):240-253. doi: 10.1038/s41590-020-00827-8. Epub 2021 Jan 11. Nat Immunol. 2021. PMID: 33432228 Free PMC article.
63 results